Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Supply Chain Analysis
3.5.1. Supply Side Participants and their Roles
3.5.1.1. Manufacturer
3.5.1.2. Mid-Level Participants (Traders)
3.5.1.3. Wholesalers and Distributors
3.5.2. Value Added and Value Created at Node in the Supply Chain
3.5.3. List of Raw Material Suppliers
3.5.4. List of Existing and Potential Buyer’s
3.6. Investment Feasibility Matrix
3.7. Value Chain Analysis
3.7.1. Profit Margin Analysis
3.7.2. Wholesalers and Distributors
3.7.3. Retailers
3.8. PESTLE and Porter’s Analysis
3.9. Regulatory Landscape
3.9.1. By Key Regions
3.9.2. By Key Countries
3.10. Regional Parent Market Outlook
3.11. Production and Consumption Statistics
3.12. Import and Export Statistics
4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034
4.1. Historical Market Size Value (US$ million) & Volume (Units) Analysis, 2019 to 2023
4.2. Current and Future Market Size Value (US$ million) & Volume (Units) Projections, 2024 to 2034
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Drug Class
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ million) & Volume (Units) Analysis By Drug Class, 2019 to 2023
5.3. Current and Future Market Size Value (US$ million) & Volume (Units) Analysis and Forecast By Drug Class, 2024 to 2034
5.3.1. Anti-inflammatory
5.3.2. Bronchodilators
5.3.3. Combination Therapy
5.4. Y-o-Y Growth Trend Analysis By Drug Class, 2019 to 2023
5.5. Absolute $ Opportunity Analysis By Drug Class, 2024 to 2034
6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Product
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ million) & Volume (Units) Analysis By Product, 2019 to 2023
6.3. Current and Future Market Size Value (US$ million) & Volume (Units) Analysis and Forecast By Product, 2024 to 2034
6.3.1. Inhalers
6.3.1.1. Dry Powder
6.3.1.2. Metered Dose
6.3.1.3. Soft Mist
6.3.2. Nebulizers
6.4. Y-o-Y Growth Trend Analysis By Product, 2019 to 2023
6.5. Absolute $ Opportunity Analysis By Product, 2024 to 2034
7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Route of Administration
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ million) & Volume (Units) Analysis By Route of Administration, 2019 to 2023
7.3. Current and Future Market Size Value (US$ million) & Volume (Units) Analysis and Forecast By Route of Administration, 2024 to 2034
7.3.1. Oral
7.3.2. Inhaled
7.3.3. Others
7.4. Y-o-Y Growth Trend Analysis By Route of Administration, 2019 to 2023
7.5. Absolute $ Opportunity Analysis By Route of Administration, 2024 to 2034
8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ million) & Volume (Units) Analysis By Region, 2019 to 2023
8.3. Current Market Size Value (US$ million) & Volume (Units) Analysis and Forecast By Region, 2024 to 2034
8.3.1. North America
8.3.2. Latin America
8.3.3. Western Europe
8.3.4. Eastern Europe
8.3.5. South Asia and Pacific
8.3.6. East Asia
8.3.7. Middle East and Africa
8.4. Market Attractiveness Analysis By Region
9. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
9.1. Historical Market Size Value (US$ million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023
9.2. Market Size Value (US$ million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034
9.2.1. By Country
9.2.1.1. United States
9.2.1.2. Canada
9.2.2. By Drug Class
9.2.3. By Product
9.2.4. By Route of Administration
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Drug Class
9.3.3. By Product
9.3.4. By Route of Administration
9.4. Key Takeaways
10. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
10.1. Historical Market Size Value (US$ million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023
10.2. Market Size Value (US$ million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034
10.2.1. By Country
10.2.1.1. Brazil
10.2.1.2. Mexico
10.2.1.3. Rest of Latin America
10.2.2. By Drug Class
10.2.3. By Product
10.2.4. By Route of Administration
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Drug Class
10.3.3. By Product
10.3.4. By Route of Administration
10.4. Key Takeaways
11. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
11.1. Historical Market Size Value (US$ million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023
11.2. Market Size Value (US$ million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. United Kingdom
11.2.1.3. France
11.2.1.4. Spain
11.2.1.5. Italy
11.2.1.6. Rest of Western Europe
11.2.2. By Drug Class
11.2.3. By Product
11.2.4. By Route of Administration
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Drug Class
11.3.3. By Product
11.3.4. By Route of Administration
11.4. Key Takeaways
12. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
12.1. Historical Market Size Value (US$ million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023
12.2. Market Size Value (US$ million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034
12.2.1. By Country
12.2.1.1. Poland
12.2.1.2. Russia
12.2.1.3. Czech Republic
12.2.1.4. Romania
12.2.1.5. Rest of Eastern Europe
12.2.2. By Drug Class
12.2.3. By Product
12.2.4. By Route of Administration
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Drug Class
12.3.3. By Product
12.3.4. By Route of Administration
12.4. Key Takeaways
13. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
13.1. Historical Market Size Value (US$ million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023
13.2. Market Size Value (US$ million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034
13.2.1. By Country
13.2.1.1. India
13.2.1.2. Bangladesh
13.2.1.3. Australia
13.2.1.4. New Zealand
13.2.1.5. Rest of South Asia and Pacific
13.2.2. By Drug Class
13.2.3. By Product
13.2.4. By Route of Administration
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Drug Class
13.3.3. By Product
13.3.4. By Route of Administration
13.4. Key Takeaways
14. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
14.1. Historical Market Size Value (US$ million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023
14.2. Market Size Value (US$ million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034
14.2.1. By Country
14.2.1.1. China
14.2.1.2. Japan
14.2.1.3. South Korea
14.2.2. By Drug Class
14.2.3. By Product
14.2.4. By Route of Administration
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Drug Class
14.3.3. By Product
14.3.4. By Route of Administration
14.4. Key Takeaways
15. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
15.1. Historical Market Size Value (US$ million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023
15.2. Market Size Value (US$ million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034
15.2.1. By Country
15.2.1.1. GCC Countries
15.2.1.2. South Africa
15.2.1.3. Israel
15.2.1.4. Rest of Middle East and Africa
15.2.2. By Drug Class
15.2.3. By Product
15.2.4. By Route of Administration
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Drug Class
15.3.3. By Product
15.3.4. By Route of Administration
15.4. Key Takeaways
16. Key Countries Market Analysis
16.1. United States
16.1.1. Pricing Analysis
16.1.2. Market Share Analysis, 2024
16.1.2.1. By Drug Class
16.1.2.2. By Product
16.1.2.3. By Route of Administration
16.2. Canada
16.2.1. Pricing Analysis
16.2.2. Market Share Analysis, 2024
16.2.2.1. By Drug Class
16.2.2.2. By Product
16.2.2.3. By Route of Administration
16.3. Brazil
16.3.1. Pricing Analysis
16.3.2. Market Share Analysis, 2024
16.3.2.1. By Drug Class
16.3.2.2. By Product
16.3.2.3. By Route of Administration
16.4. Mexico
16.4.1. Pricing Analysis
16.4.2. Market Share Analysis, 2024
16.4.2.1. By Drug Class
16.4.2.2. By Product
16.4.2.3. By Route of Administration
16.5. Germany
16.5.1. Pricing Analysis
16.5.2. Market Share Analysis, 2024
16.5.2.1. By Drug Class
16.5.2.2. By Product
16.5.2.3. By Route of Administration
16.6. United Kingdom
16.6.1. Pricing Analysis
16.6.2. Market Share Analysis, 2024
16.6.2.1. By Drug Class
16.6.2.2. By Product
16.6.2.3. By Route of Administration
16.7. France
16.7.1. Pricing Analysis
16.7.2. Market Share Analysis, 2024
16.7.2.1. By Drug Class
16.7.2.2. By Product
16.7.2.3. By Route of Administration
16.8. Spain
16.8.1. Pricing Analysis
16.8.2. Market Share Analysis, 2024
16.8.2.1. By Drug Class
16.8.2.2. By Product
16.8.2.3. By Route of Administration
16.9. Italy
16.9.1. Pricing Analysis
16.9.2. Market Share Analysis, 2024
16.9.2.1. By Drug Class
16.9.2.2. By Product
16.9.2.3. By Route of Administration
16.10. Poland
16.10.1. Pricing Analysis
16.10.2. Market Share Analysis, 2024
16.10.2.1. By Drug Class
16.10.2.2. By Product
16.10.2.3. By Route of Administration
16.11. Russia
16.11.1. Pricing Analysis
16.11.2. Market Share Analysis, 2024
16.11.2.1. By Drug Class
16.11.2.2. By Product
16.11.2.3. By Route of Administration
16.12. Czech Republic
16.12.1. Pricing Analysis
16.12.2. Market Share Analysis, 2024
16.12.2.1. By Drug Class
16.12.2.2. By Product
16.12.2.3. By Route of Administration
16.13. Romania
16.13.1. Pricing Analysis
16.13.2. Market Share Analysis, 2024
16.13.2.1. By Drug Class
16.13.2.2. By Product
16.13.2.3. By Route of Administration
16.14. India
16.14.1. Pricing Analysis
16.14.2. Market Share Analysis, 2024
16.14.2.1. By Drug Class
16.14.2.2. By Product
16.14.2.3. By Route of Administration
16.15. Bangladesh
16.15.1. Pricing Analysis
16.15.2. Market Share Analysis, 2024
16.15.2.1. By Drug Class
16.15.2.2. By Product
16.15.2.3. By Route of Administration
16.16. Australia
16.16.1. Pricing Analysis
16.16.2. Market Share Analysis, 2024
16.16.2.1. By Drug Class
16.16.2.2. By Product
16.16.2.3. By Route of Administration
16.17. New Zealand
16.17.1. Pricing Analysis
16.17.2. Market Share Analysis, 2024
16.17.2.1. By Drug Class
16.17.2.2. By Product
16.17.2.3. By Route of Administration
16.18. China
16.18.1. Pricing Analysis
16.18.2. Market Share Analysis, 2024
16.18.2.1. By Drug Class
16.18.2.2. By Product
16.18.2.3. By Route of Administration
16.19. Japan
16.19.1. Pricing Analysis
16.19.2. Market Share Analysis, 2024
16.19.2.1. By Drug Class
16.19.2.2. By Product
16.19.2.3. By Route of Administration
16.20. South Korea
16.20.1. Pricing Analysis
16.20.2. Market Share Analysis, 2024
16.20.2.1. By Drug Class
16.20.2.2. By Product
16.20.2.3. By Route of Administration
16.21. GCC Countries
16.21.1. Pricing Analysis
16.21.2. Market Share Analysis, 2024
16.21.2.1. By Drug Class
16.21.2.2. By Product
16.21.2.3. By Route of Administration
16.22. South Africa
16.22.1. Pricing Analysis
16.22.2. Market Share Analysis, 2024
16.22.2.1. By Drug Class
16.22.2.2. By Product
16.22.2.3. By Route of Administration
16.23. Israel
16.23.1. Pricing Analysis
16.23.2. Market Share Analysis, 2024
16.23.2.1. By Drug Class
16.23.2.2. By Product
16.23.2.3. By Route of Administration
17. Market Structure Analysis
17.1. Competition Dashboard
17.2. Competition Benchmarking
17.3. Market Share Analysis of Top Players
17.3.1. By Regional
17.3.2. By Drug Class
17.3.3. By Product
17.3.4. By Route of Administration
18. Competition Analysis
18.1. Competition Deep Dive
18.1.1. Teva Pharmaceutical Industries Ltd.
18.1.1.1. Overview
18.1.1.2. Product Portfolio
18.1.1.3. Profitability by Market Segments
18.1.1.4. Sales Footprint
18.1.1.5. Strategy Overview
18.1.1.5.1. Marketing Strategy
18.1.1.5.2. Product Strategy
18.1.1.5.3. Channel Strategy
18.1.2. GSK plc
18.1.2.1. Overview
18.1.2.2. Product Portfolio
18.1.2.3. Profitability by Market Segments
18.1.2.4. Sales Footprint
18.1.2.5. Strategy Overview
18.1.2.5.1. Marketing Strategy
18.1.2.5.2. Product Strategy
18.1.2.5.3. Channel Strategy
18.1.3. Merck & Co., Inc.
18.1.3.1. Overview
18.1.3.2. Product Portfolio
18.1.3.3. Profitability by Market Segments
18.1.3.4. Sales Footprint
18.1.3.5. Strategy Overview
18.1.3.5.1. Marketing Strategy
18.1.3.5.2. Product Strategy
18.1.3.5.3. Channel Strategy
18.1.4. F. Hoffmann-La Roche Ltd
18.1.4.1. Overview
18.1.4.2. Product Portfolio
18.1.4.3. Profitability by Market Segments
18.1.4.4. Sales Footprint
18.1.4.5. Strategy Overview
18.1.4.5.1. Marketing Strategy
18.1.4.5.2. Product Strategy
18.1.4.5.3. Channel Strategy
18.1.5. AstraZeneca
18.1.5.1. Overview
18.1.5.2. Product Portfolio
18.1.5.3. Profitability by Market Segments
18.1.5.4. Sales Footprint
18.1.5.5. Strategy Overview
18.1.5.5.1. Marketing Strategy
18.1.5.5.2. Product Strategy
18.1.5.5.3. Channel Strategy
18.1.6. Boehringer Ingelheim International GmbH
18.1.6.1. Overview
18.1.6.2. Product Portfolio
18.1.6.3. Profitability by Market Segments
18.1.6.4. Sales Footprint
18.1.6.5. Strategy Overview
18.1.6.5.1. Marketing Strategy
18.1.6.5.2. Product Strategy
18.1.6.5.3. Channel Strategy
18.1.7. Sanofi.
18.1.7.1. Overview
18.1.7.2. Product Portfolio
18.1.7.3. Profitability by Market Segments
18.1.7.4. Sales Footprint
18.1.7.5. Strategy Overview
18.1.7.5.1. Marketing Strategy
18.1.7.5.2. Product Strategy
18.1.7.5.3. Channel Strategy
18.1.8. Koninklijke Philips N.V.
18.1.8.1. Overview
18.1.8.2. Product Portfolio
18.1.8.3. Profitability by Market Segments
18.1.8.4. Sales Footprint
18.1.8.5. Strategy Overview
18.1.8.5.1. Marketing Strategy
18.1.8.5.2. Product Strategy
18.1.8.5.3. Channel Strategy
18.1.9. BD
18.1.9.1. Overview
18.1.9.2. Product Portfolio
18.1.9.3. Profitability by Market Segments
18.1.9.4. Sales Footprint
18.1.9.5. Strategy Overview
18.1.9.5.1. Marketing Strategy
18.1.9.5.2. Product Strategy
18.1.9.5.3. Channel Strategy
18.1.10. Covis Pharma
18.1.10.1. Overview
18.1.10.2. Product Portfolio
18.1.10.3. Profitability by Market Segments
18.1.10.4. Sales Footprint
18.1.10.5. Strategy Overview
18.1.10.5.1. Marketing Strategy
18.1.10.5.2. Product Strategy
18.1.10.5.3. Channel Strategy
19. Assumptions & Acronyms Used
20. Research Methodology
List of Tables
Table 1: Global Market Value (US$ million) Forecast by Region, 2019 to 2034
Table 2: Global Market Volume (Units) Forecast by Region, 2019 to 2034
Table 3: Global Market Value (US$ million) Forecast by Drug Class, 2019 to 2034
Table 4: Global Market Volume (Units) Forecast by Drug Class, 2019 to 2034
Table 5: Global Market Value (US$ million) Forecast by Product, 2019 to 2034
Table 6: Global Market Volume (Units) Forecast by Product, 2019 to 2034
Table 7: Global Market Value (US$ million) Forecast by Route of Administration, 2019 to 2034
Table 8: Global Market Volume (Units) Forecast by Route of Administration, 2019 to 2034
Table 9: North America Market Value (US$ million) Forecast by Country, 2019 to 2034
Table 10: North America Market Volume (Units) Forecast by Country, 2019 to 2034
Table 11: North America Market Value (US$ million) Forecast by Drug Class, 2019 to 2034
Table 12: North America Market Volume (Units) Forecast by Drug Class, 2019 to 2034
Table 13: North America Market Value (US$ million) Forecast by Product, 2019 to 2034
Table 14: North America Market Volume (Units) Forecast by Product, 2019 to 2034
Table 15: North America Market Value (US$ million) Forecast by Route of Administration, 2019 to 2034
Table 16: North America Market Volume (Units) Forecast by Route of Administration, 2019 to 2034
Table 17: Latin America Market Value (US$ million) Forecast by Country, 2019 to 2034
Table 18: Latin America Market Volume (Units) Forecast by Country, 2019 to 2034
Table 19: Latin America Market Value (US$ million) Forecast by Drug Class, 2019 to 2034
Table 20: Latin America Market Volume (Units) Forecast by Drug Class, 2019 to 2034
Table 21: Latin America Market Value (US$ million) Forecast by Product, 2019 to 2034
Table 22: Latin America Market Volume (Units) Forecast by Product, 2019 to 2034
Table 23: Latin America Market Value (US$ million) Forecast by Route of Administration, 2019 to 2034
Table 24: Latin America Market Volume (Units) Forecast by Route of Administration, 2019 to 2034
Table 25: Western Europe Market Value (US$ million) Forecast by Country, 2019 to 2034
Table 26: Western Europe Market Volume (Units) Forecast by Country, 2019 to 2034
Table 27: Western Europe Market Value (US$ million) Forecast by Drug Class, 2019 to 2034
Table 28: Western Europe Market Volume (Units) Forecast by Drug Class, 2019 to 2034
Table 29: Western Europe Market Value (US$ million) Forecast by Product, 2019 to 2034
Table 30: Western Europe Market Volume (Units) Forecast by Product, 2019 to 2034
Table 31: Western Europe Market Value (US$ million) Forecast by Route of Administration, 2019 to 2034
Table 32: Western Europe Market Volume (Units) Forecast by Route of Administration, 2019 to 2034
Table 33: Eastern Europe Market Value (US$ million) Forecast by Country, 2019 to 2034
Table 34: Eastern Europe Market Volume (Units) Forecast by Country, 2019 to 2034
Table 35: Eastern Europe Market Value (US$ million) Forecast by Drug Class, 2019 to 2034
Table 36: Eastern Europe Market Volume (Units) Forecast by Drug Class, 2019 to 2034
Table 37: Eastern Europe Market Value (US$ million) Forecast by Product, 2019 to 2034
Table 38: Eastern Europe Market Volume (Units) Forecast by Product, 2019 to 2034
Table 39: Eastern Europe Market Value (US$ million) Forecast by Route of Administration, 2019 to 2034
Table 40: Eastern Europe Market Volume (Units) Forecast by Route of Administration, 2019 to 2034
Table 41: South Asia and Pacific Market Value (US$ million) Forecast by Country, 2019 to 2034
Table 42: South Asia and Pacific Market Volume (Units) Forecast by Country, 2019 to 2034
Table 43: South Asia and Pacific Market Value (US$ million) Forecast by Drug Class, 2019 to 2034
Table 44: South Asia and Pacific Market Volume (Units) Forecast by Drug Class, 2019 to 2034
Table 45: South Asia and Pacific Market Value (US$ million) Forecast by Product, 2019 to 2034
Table 46: South Asia and Pacific Market Volume (Units) Forecast by Product, 2019 to 2034
Table 47: South Asia and Pacific Market Value (US$ million) Forecast by Route of Administration, 2019 to 2034
Table 48: South Asia and Pacific Market Volume (Units) Forecast by Route of Administration, 2019 to 2034
Table 49: East Asia Market Value (US$ million) Forecast by Country, 2019 to 2034
Table 50: East Asia Market Volume (Units) Forecast by Country, 2019 to 2034
Table 51: East Asia Market Value (US$ million) Forecast by Drug Class, 2019 to 2034
Table 52: East Asia Market Volume (Units) Forecast by Drug Class, 2019 to 2034
Table 53: East Asia Market Value (US$ million) Forecast by Product, 2019 to 2034
Table 54: East Asia Market Volume (Units) Forecast by Product, 2019 to 2034
Table 55: East Asia Market Value (US$ million) Forecast by Route of Administration, 2019 to 2034
Table 56: East Asia Market Volume (Units) Forecast by Route of Administration, 2019 to 2034
Table 57: Middle East and Africa Market Value (US$ million) Forecast by Country, 2019 to 2034
Table 58: Middle East and Africa Market Volume (Units) Forecast by Country, 2019 to 2034
Table 59: Middle East and Africa Market Value (US$ million) Forecast by Drug Class, 2019 to 2034
Table 60: Middle East and Africa Market Volume (Units) Forecast by Drug Class, 2019 to 2034
Table 61: Middle East and Africa Market Value (US$ million) Forecast by Product, 2019 to 2034
Table 62: Middle East and Africa Market Volume (Units) Forecast by Product, 2019 to 2034
Table 63: Middle East and Africa Market Value (US$ million) Forecast by Route of Administration, 2019 to 2034
Table 64: Middle East and Africa Market Volume (Units) Forecast by Route of Administration, 2019 to 2034
List of Charts
Figure 1: Global Market Value (US$ million) by Drug Class, 2024 to 2034
Figure 2: Global Market Value (US$ million) by Product, 2024 to 2034
Figure 3: Global Market Value (US$ million) by Route of Administration, 2024 to 2034
Figure 4: Global Market Value (US$ million) by Region, 2024 to 2034
Figure 5: Global Market Value (US$ million) Analysis by Region, 2019 to 2034
Figure 6: Global Market Volume (Units) Analysis by Region, 2019 to 2034
Figure 7: Global Market Value Share (%) and BPS Analysis by Region, 2024 to 2034
Figure 8: Global Market Y-o-Y Growth (%) Projections by Region, 2024 to 2034
Figure 9: Global Market Value (US$ million) Analysis by Drug Class, 2019 to 2034
Figure 10: Global Market Volume (Units) Analysis by Drug Class, 2019 to 2034
Figure 11: Global Market Value Share (%) and BPS Analysis by Drug Class, 2024 to 2034
Figure 12: Global Market Y-o-Y Growth (%) Projections by Drug Class, 2024 to 2034
Figure 13: Global Market Value (US$ million) Analysis by Product, 2019 to 2034
Figure 14: Global Market Volume (Units) Analysis by Product, 2019 to 2034
Figure 15: Global Market Value Share (%) and BPS Analysis by Product, 2024 to 2034
Figure 16: Global Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034
Figure 17: Global Market Value (US$ million) Analysis by Route of Administration, 2019 to 2034
Figure 18: Global Market Volume (Units) Analysis by Route of Administration, 2019 to 2034
Figure 19: Global Market Value Share (%) and BPS Analysis by Route of Administration, 2024 to 2034
Figure 20: Global Market Y-o-Y Growth (%) Projections by Route of Administration, 2024 to 2034
Figure 21: Global Market Attractiveness by Drug Class, 2024 to 2034
Figure 22: Global Market Attractiveness by Product, 2024 to 2034
Figure 23: Global Market Attractiveness by Route of Administration, 2024 to 2034
Figure 24: Global Market Attractiveness by Region, 2024 to 2034
Figure 25: North America Market Value (US$ million) by Drug Class, 2024 to 2034
Figure 26: North America Market Value (US$ million) by Product, 2024 to 2034
Figure 27: North America Market Value (US$ million) by Route of Administration, 2024 to 2034
Figure 28: North America Market Value (US$ million) by Country, 2024 to 2034
Figure 29: North America Market Value (US$ million) Analysis by Country, 2019 to 2034
Figure 30: North America Market Volume (Units) Analysis by Country, 2019 to 2034
Figure 31: North America Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 32: North America Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 33: North America Market Value (US$ million) Analysis by Drug Class, 2019 to 2034
Figure 34: North America Market Volume (Units) Analysis by Drug Class, 2019 to 2034
Figure 35: North America Market Value Share (%) and BPS Analysis by Drug Class, 2024 to 2034
Figure 36: North America Market Y-o-Y Growth (%) Projections by Drug Class, 2024 to 2034
Figure 37: North America Market Value (US$ million) Analysis by Product, 2019 to 2034
Figure 38: North America Market Volume (Units) Analysis by Product, 2019 to 2034
Figure 39: North America Market Value Share (%) and BPS Analysis by Product, 2024 to 2034
Figure 40: North America Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034
Figure 41: North America Market Value (US$ million) Analysis by Route of Administration, 2019 to 2034
Figure 42: North America Market Volume (Units) Analysis by Route of Administration, 2019 to 2034
Figure 43: North America Market Value Share (%) and BPS Analysis by Route of Administration, 2024 to 2034
Figure 44: North America Market Y-o-Y Growth (%) Projections by Route of Administration, 2024 to 2034
Figure 45: North America Market Attractiveness by Drug Class, 2024 to 2034
Figure 46: North America Market Attractiveness by Product, 2024 to 2034
Figure 47: North America Market Attractiveness by Route of Administration, 2024 to 2034
Figure 48: North America Market Attractiveness by Country, 2024 to 2034
Figure 49: Latin America Market Value (US$ million) by Drug Class, 2024 to 2034
Figure 50: Latin America Market Value (US$ million) by Product, 2024 to 2034
Figure 51: Latin America Market Value (US$ million) by Route of Administration, 2024 to 2034
Figure 52: Latin America Market Value (US$ million) by Country, 2024 to 2034
Figure 53: Latin America Market Value (US$ million) Analysis by Country, 2019 to 2034
Figure 54: Latin America Market Volume (Units) Analysis by Country, 2019 to 2034
Figure 55: Latin America Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 56: Latin America Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 57: Latin America Market Value (US$ million) Analysis by Drug Class, 2019 to 2034
Figure 58: Latin America Market Volume (Units) Analysis by Drug Class, 2019 to 2034
Figure 59: Latin America Market Value Share (%) and BPS Analysis by Drug Class, 2024 to 2034
Figure 60: Latin America Market Y-o-Y Growth (%) Projections by Drug Class, 2024 to 2034
Figure 61: Latin America Market Value (US$ million) Analysis by Product, 2019 to 2034
Figure 62: Latin America Market Volume (Units) Analysis by Product, 2019 to 2034
Figure 63: Latin America Market Value Share (%) and BPS Analysis by Product, 2024 to 2034
Figure 64: Latin America Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034
Figure 65: Latin America Market Value (US$ million) Analysis by Route of Administration, 2019 to 2034
Figure 66: Latin America Market Volume (Units) Analysis by Route of Administration, 2019 to 2034
Figure 67: Latin America Market Value Share (%) and BPS Analysis by Route of Administration, 2024 to 2034
Figure 68: Latin America Market Y-o-Y Growth (%) Projections by Route of Administration, 2024 to 2034
Figure 69: Latin America Market Attractiveness by Drug Class, 2024 to 2034
Figure 70: Latin America Market Attractiveness by Product, 2024 to 2034
Figure 71: Latin America Market Attractiveness by Route of Administration, 2024 to 2034
Figure 72: Latin America Market Attractiveness by Country, 2024 to 2034
Figure 73: Western Europe Market Value (US$ million) by Drug Class, 2024 to 2034
Figure 74: Western Europe Market Value (US$ million) by Product, 2024 to 2034
Figure 75: Western Europe Market Value (US$ million) by Route of Administration, 2024 to 2034
Figure 76: Western Europe Market Value (US$ million) by Country, 2024 to 2034
Figure 77: Western Europe Market Value (US$ million) Analysis by Country, 2019 to 2034
Figure 78: Western Europe Market Volume (Units) Analysis by Country, 2019 to 2034
Figure 79: Western Europe Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 80: Western Europe Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 81: Western Europe Market Value (US$ million) Analysis by Drug Class, 2019 to 2034
Figure 82: Western Europe Market Volume (Units) Analysis by Drug Class, 2019 to 2034
Figure 83: Western Europe Market Value Share (%) and BPS Analysis by Drug Class, 2024 to 2034
Figure 84: Western Europe Market Y-o-Y Growth (%) Projections by Drug Class, 2024 to 2034
Figure 85: Western Europe Market Value (US$ million) Analysis by Product, 2019 to 2034
Figure 86: Western Europe Market Volume (Units) Analysis by Product, 2019 to 2034
Figure 87: Western Europe Market Value Share (%) and BPS Analysis by Product, 2024 to 2034
Figure 88: Western Europe Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034
Figure 89: Western Europe Market Value (US$ million) Analysis by Route of Administration, 2019 to 2034
Figure 90: Western Europe Market Volume (Units) Analysis by Route of Administration, 2019 to 2034
Figure 91: Western Europe Market Value Share (%) and BPS Analysis by Route of Administration, 2024 to 2034
Figure 92: Western Europe Market Y-o-Y Growth (%) Projections by Route of Administration, 2024 to 2034
Figure 93: Western Europe Market Attractiveness by Drug Class, 2024 to 2034
Figure 94: Western Europe Market Attractiveness by Product, 2024 to 2034
Figure 95: Western Europe Market Attractiveness by Route of Administration, 2024 to 2034
Figure 96: Western Europe Market Attractiveness by Country, 2024 to 2034
Figure 97: Eastern Europe Market Value (US$ million) by Drug Class, 2024 to 2034
Figure 98: Eastern Europe Market Value (US$ million) by Product, 2024 to 2034
Figure 99: Eastern Europe Market Value (US$ million) by Route of Administration, 2024 to 2034
Figure 100: Eastern Europe Market Value (US$ million) by Country, 2024 to 2034
Figure 101: Eastern Europe Market Value (US$ million) Analysis by Country, 2019 to 2034
Figure 102: Eastern Europe Market Volume (Units) Analysis by Country, 2019 to 2034
Figure 103: Eastern Europe Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 104: Eastern Europe Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 105: Eastern Europe Market Value (US$ million) Analysis by Drug Class, 2019 to 2034
Figure 106: Eastern Europe Market Volume (Units) Analysis by Drug Class, 2019 to 2034
Figure 107: Eastern Europe Market Value Share (%) and BPS Analysis by Drug Class, 2024 to 2034
Figure 108: Eastern Europe Market Y-o-Y Growth (%) Projections by Drug Class, 2024 to 2034
Figure 109: Eastern Europe Market Value (US$ million) Analysis by Product, 2019 to 2034
Figure 110: Eastern Europe Market Volume (Units) Analysis by Product, 2019 to 2034
Figure 111: Eastern Europe Market Value Share (%) and BPS Analysis by Product, 2024 to 2034
Figure 112: Eastern Europe Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034
Figure 113: Eastern Europe Market Value (US$ million) Analysis by Route of Administration, 2019 to 2034
Figure 114: Eastern Europe Market Volume (Units) Analysis by Route of Administration, 2019 to 2034
Figure 115: Eastern Europe Market Value Share (%) and BPS Analysis by Route of Administration, 2024 to 2034
Figure 116: Eastern Europe Market Y-o-Y Growth (%) Projections by Route of Administration, 2024 to 2034
Figure 117: Eastern Europe Market Attractiveness by Drug Class, 2024 to 2034
Figure 118: Eastern Europe Market Attractiveness by Product, 2024 to 2034
Figure 119: Eastern Europe Market Attractiveness by Route of Administration, 2024 to 2034
Figure 120: Eastern Europe Market Attractiveness by Country, 2024 to 2034
Figure 121: South Asia and Pacific Market Value (US$ million) by Drug Class, 2024 to 2034
Figure 122: South Asia and Pacific Market Value (US$ million) by Product, 2024 to 2034
Figure 123: South Asia and Pacific Market Value (US$ million) by Route of Administration, 2024 to 2034
Figure 124: South Asia and Pacific Market Value (US$ million) by Country, 2024 to 2034
Figure 125: South Asia and Pacific Market Value (US$ million) Analysis by Country, 2019 to 2034
Figure 126: South Asia and Pacific Market Volume (Units) Analysis by Country, 2019 to 2034
Figure 127: South Asia and Pacific Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 128: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 129: South Asia and Pacific Market Value (US$ million) Analysis by Drug Class, 2019 to 2034
Figure 130: South Asia and Pacific Market Volume (Units) Analysis by Drug Class, 2019 to 2034
Figure 131: South Asia and Pacific Market Value Share (%) and BPS Analysis by Drug Class, 2024 to 2034
Figure 132: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Drug Class, 2024 to 2034
Figure 133: South Asia and Pacific Market Value (US$ million) Analysis by Product, 2019 to 2034
Figure 134: South Asia and Pacific Market Volume (Units) Analysis by Product, 2019 to 2034
Figure 135: South Asia and Pacific Market Value Share (%) and BPS Analysis by Product, 2024 to 2034
Figure 136: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034
Figure 137: South Asia and Pacific Market Value (US$ million) Analysis by Route of Administration, 2019 to 2034
Figure 138: South Asia and Pacific Market Volume (Units) Analysis by Route of Administration, 2019 to 2034
Figure 139: South Asia and Pacific Market Value Share (%) and BPS Analysis by Route of Administration, 2024 to 2034
Figure 140: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Route of Administration, 2024 to 2034
Figure 141: South Asia and Pacific Market Attractiveness by Drug Class, 2024 to 2034
Figure 142: South Asia and Pacific Market Attractiveness by Product, 2024 to 2034
Figure 143: South Asia and Pacific Market Attractiveness by Route of Administration, 2024 to 2034
Figure 144: South Asia and Pacific Market Attractiveness by Country, 2024 to 2034
Figure 145: East Asia Market Value (US$ million) by Drug Class, 2024 to 2034
Figure 146: East Asia Market Value (US$ million) by Product, 2024 to 2034
Figure 147: East Asia Market Value (US$ million) by Route of Administration, 2024 to 2034
Figure 148: East Asia Market Value (US$ million) by Country, 2024 to 2034
Figure 149: East Asia Market Value (US$ million) Analysis by Country, 2019 to 2034
Figure 150: East Asia Market Volume (Units) Analysis by Country, 2019 to 2034
Figure 151: East Asia Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 152: East Asia Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 153: East Asia Market Value (US$ million) Analysis by Drug Class, 2019 to 2034
Figure 154: East Asia Market Volume (Units) Analysis by Drug Class, 2019 to 2034
Figure 155: East Asia Market Value Share (%) and BPS Analysis by Drug Class, 2024 to 2034
Figure 156: East Asia Market Y-o-Y Growth (%) Projections by Drug Class, 2024 to 2034
Figure 157: East Asia Market Value (US$ million) Analysis by Product, 2019 to 2034
Figure 158: East Asia Market Volume (Units) Analysis by Product, 2019 to 2034
Figure 159: East Asia Market Value Share (%) and BPS Analysis by Product, 2024 to 2034
Figure 160: East Asia Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034
Figure 161: East Asia Market Value (US$ million) Analysis by Route of Administration, 2019 to 2034
Figure 162: East Asia Market Volume (Units) Analysis by Route of Administration, 2019 to 2034
Figure 163: East Asia Market Value Share (%) and BPS Analysis by Route of Administration, 2024 to 2034
Figure 164: East Asia Market Y-o-Y Growth (%) Projections by Route of Administration, 2024 to 2034
Figure 165: East Asia Market Attractiveness by Drug Class, 2024 to 2034
Figure 166: East Asia Market Attractiveness by Product, 2024 to 2034
Figure 167: East Asia Market Attractiveness by Route of Administration, 2024 to 2034
Figure 168: East Asia Market Attractiveness by Country, 2024 to 2034
Figure 169: Middle East and Africa Market Value (US$ million) by Drug Class, 2024 to 2034
Figure 170: Middle East and Africa Market Value (US$ million) by Product, 2024 to 2034
Figure 171: Middle East and Africa Market Value (US$ million) by Route of Administration, 2024 to 2034
Figure 172: Middle East and Africa Market Value (US$ million) by Country, 2024 to 2034
Figure 173: Middle East and Africa Market Value (US$ million) Analysis by Country, 2019 to 2034
Figure 174: Middle East and Africa Market Volume (Units) Analysis by Country, 2019 to 2034
Figure 175: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 176: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 177: Middle East and Africa Market Value (US$ million) Analysis by Drug Class, 2019 to 2034
Figure 178: Middle East and Africa Market Volume (Units) Analysis by Drug Class, 2019 to 2034
Figure 179: Middle East and Africa Market Value Share (%) and BPS Analysis by Drug Class, 2024 to 2034
Figure 180: Middle East and Africa Market Y-o-Y Growth (%) Projections by Drug Class, 2024 to 2034
Figure 181: Middle East and Africa Market Value (US$ million) Analysis by Product, 2019 to 2034
Figure 182: Middle East and Africa Market Volume (Units) Analysis by Product, 2019 to 2034
Figure 183: Middle East and Africa Market Value Share (%) and BPS Analysis by Product, 2024 to 2034
Figure 184: Middle East and Africa Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034
Figure 185: Middle East and Africa Market Value (US$ million) Analysis by Route of Administration, 2019 to 2034
Figure 186: Middle East and Africa Market Volume (Units) Analysis by Route of Administration, 2019 to 2034
Figure 187: Middle East and Africa Market Value Share (%) and BPS Analysis by Route of Administration, 2024 to 2034
Figure 188: Middle East and Africa Market Y-o-Y Growth (%) Projections by Route of Administration, 2024 to 2034
Figure 189: Middle East and Africa Market Attractiveness by Drug Class, 2024 to 2034
Figure 190: Middle East and Africa Market Attractiveness by Product, 2024 to 2034
Figure 191: Middle East and Africa Market Attractiveness by Route of Administration, 2024 to 2034
Figure 192: Middle East and Africa Market Attractiveness by Country, 2024 to 2034
